Epithelial Cell Transforming Sequence 2 Oncogene (ECT2) Peptide
ECT2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all ECT2 products
- ECT2 (Epithelial Cell Transforming Sequence 2 Oncogene (ECT2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KKHTADENPD KSTLEKAIGS LKEVMTHINE DKRKTEAQKQ IFDVVYEVDG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ECT2 antibody,
Alternative Names: ECT2 control peptide, ECT2 antibody Blocking Peptide, Anti-ECT2 Blocking Peptide, Epithelial Cell Transforming Sequence 2 Oncogene Blocking Peptide, FLJ10461 Blocking Peptide, MGC138291 Blocking Peptide, ECT2, ECT-2, ECT 2, ECT-2 Blocking Peptide, ECT 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ECT2 (Epithelial Cell Transforming Sequence 2 Oncogene (ECT2))
- Background
- ECT2 is a transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of ECT2 is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis.
- Molecular Weight
- 100 kDa
-
You are here:
